Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ligand. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3,5-dialkyl pyrazole ligand enables C-Cl greater than C-OTf selectivity in Buchwald-Hartwig reactions, offering cost-effective pharma intermediate synthesis.
Patent CN111100124B discloses a novel linear phenanthroline ligand enhancing palladium catalyst efficiency. Discover cost-effective synthesis routes and supply chain advantages for industrial scale-up.
Patent CN120136859A reveals a novel binaphthyl ligand for synthesizing high-purity seven-membered nitrogen heterocycles, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110256365B reveals a green dichlorotitanocene-catalyzed route for benzodiazepines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN108620130B reveals a stable o-carborane iridium catalyst for green imine synthesis, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Patent CN101676293B details a novel indirect route for biimidazole phosphines, offering cost reduction in catalyst manufacturing and high-purity intermediates.
Patent CN111217847B reveals novel thiosilane ligands enabling high-yield aryl boronation with superior purification and industrial scalability for pharma intermediates.
Patent CN114751937B reveals a novel Friedel-Crafts route for Baryphos intermediate. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN106995461B reveals a novel benzofuran phosphine ligand enhancing Suzuki-Miyaura coupling yields up to 99% for efficient pharmaceutical intermediate manufacturing and supply chain stability.
Patent CN116041393B reveals a novel N-N axis chiral ligand offering superior stereoselectivity and cost-effective synthesis for asymmetric catalysis applications.
Patent CN107445989B discloses novel indole-based phosphine ligands offering high catalytic activity for C-S bond formation, ensuring cost-effective pharmaceutical intermediate manufacturing.
Novel patent CN116655616B reveals efficient synthesis for chiral ligands enabling cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing processes.
Patent CN111943874A details a novel hypervalent iodine method for naproxen derivatization, offering high selectivity and metal-free synthesis for reliable pharmaceutical intermediates supply.
Novel transition-metal-free method for benzothienopyridines. High atom economy, scalable process for API intermediates and ligands.
Patent CN102040594A introduces a recyclable chiral bisoxazoline ligand with imidazolium salts, offering superior enantioselectivity and stability for pharmaceutical intermediate manufacturing.
Novel metal-free synthesis of quinolyl-triazoles via oxidative cyclization. High yields up to 97%, scalable process for pharmaceutical intermediates.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Advanced synthesis of chiral spiro bisphosphine ligands via Pd-catalyzed coupling. Delivers high-purity intermediates for asymmetric catalysis with scalable manufacturing.
Patent CN113087742B details a novel synthesis for phosphine chiral center compounds using stable oxides. Enables cost-effective production of high-purity catalysts.
Patent CN114315536A reveals a metal-free method for synthesizing axial chiral diarylethenes with high enantioselectivity, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.